Why Conventional Acute Migraine Therapies Fall Short: Medication Overuse, Triptan Resistance, and Unmet Clinical Needs

Why Conventional Acute Migraine Therapies Fall Short: Medication Overuse, Triptan Resistance, and Unmet Clinical Needs

Friday, September 11th 2026 - 2:35 PM (IST)

12 days to go

1.6k doctors attending

Friday, September 11th 2026 - 2:35 PM (IST)

Medflix

About this session

Dr. Debashish Chowdhury chairs this insightful keynote session featuring Dr. Subhash Kaul. The discussion critically examines the limitations of traditional acute therapies, including medication overuse, triptan resistance, and persistent unmet clinical needs, setting the stage for a paradigm shift in migraine management.

Other details

Registration

Free

Duration

25 min

Replay

Yes

Certificate

No

Language

English

Explore other sessions

Heart, Kidneys & Metabolism – Revolutionizing outcomes with SGLT2I & SGLT2i+DPP4i combinations

Heart, Kidneys & Metabolism – Revolutionizing outcomes with SGLT2I & SGLT2i+DPP4i combinations

31 August 2026 | 2:30 PM (IST)

Disclaimer

This program is organized by Medflix and sponsored by Pfizer Limited. Pfizer shall not be responsible for any cancellation, postponement, delay, or disruption of the webcast arising from circumstances beyond its reasonable control, including but not limited to faculty unavailability, technical failures, internet connectivity issues, or platform-related disruptions. The views, opinions, and recommendations expressed by the faculty are their own and do not necessarily reflect those of Pfizer Limited, its parent, subsidiary, or affiliate entities. Pfizer makes no representation or warranty, express or implied, regarding the accuracy, completeness, or suitability of the information presented.

For the use only of Registered Medical Practitioners or a Hospital or a Laboratory